This site is intended for healthcare professionals

Senolytics: Can we treat age-related diseases with a single drug

Read time: 4 mins
Last updated:13th Sep 2019
Published:13th Sep 2019
Source: Medthority
In the second part of our two-part series on senolytics, we focus on the handful of clinical trials that are underway for senolytics
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.